As our team at Solve M.E. continues to make breakthroughs possible in research into ME/CFS, Long Covid, and other post-infection diseases, we also stand firm in our commitment to ensuring this research is translated into new clinical tools and applications to improve the lives of our community members.
To strengthen these efforts, we’re excited to announce that Dr. David Hardy will join us as a medical advisor, and provide his scientific and medical expertise to our work. Dr. Hardy is an infectious disease specialist, and in addition to caring for patients, his work has focused on developing novel vaccines, cures, and remission strategies for human viral diseases.
We are especially impressed and touched by Dr. Hardy’s prior experience in the HIV/ AIDS disease space — Dr. Hardy has conducted research on HIV and related diseases since 1984. His research has focused on treatment and prevention of opportunistic infections, various treatments, as well as cellular and gene therapy as strategies for cure of HIV infection.
Dr. Hardy has taught at USC’s Keck School of Medicine, Johns Hopkins University School of Medicine, and UCLA’s David Geffen School of Medicine. He received his medical degree from Baylor College of Medicine, Houston, TX and completed his residency in internal medicine at Harbor-UCLA Medical Center in Torrance, California.
“I am personally delighted to support Solve M.E.’s growing activities in fostering the recognition, research and discovery of treatments for M.E. and Long Covid,” said Dr. Hardy. “My previous experiences as an HIV care provider, researcher and advocate will assist me in this welcomed endeavor.”
We’re thrilled to welcome Dr. Hardy to our team!
